An inducible nitric oxide synthase polymorphism is associated with the risk of recurrent depressive disorder

Neuroscience Letters

Volumn 486, Issue 3, 2010, Pages 184-187

  Gałecki, Piotr ^a   Maes, Michael ^b   Florkowski, Antoni ^a   Lewiński, Andrzej ^a,c   Gałecka, Elz̈bieta ^a   Bieńkiewicz, Małgorzata ^a   Szemraj, Janusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Maes Clinics   (Belgium)

^c Polish Mother's Memorial Hospital Research Institute of Lodz   (Poland)

Author keywords

Depression; Gene polymorphism; Nitric oxide synthase

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PAROXETINE; TIANEPTINE;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE PREDISPOSITION; ETHNIC GROUP; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT BRIEF DEPRESSION; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; DEPRESSIVE DISORDER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECURRENCE; RISK FACTORS;

EID: 78049356034     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.09.048     Document Type: Article

References (49)

1. Arnhold S., Andressen C., Bloch W., Mai J.K., Addicks K. NO synthase-II is transiently expressed in embryonic mouse olfactory receptor neurons. Neurosci. Lett. 1997, 229:165-168.
2. Beckamnn J.S. Peroxynitrite versus hydroxyl radical: the role of nitric oxide in superoxide dependent cerebral injury. Ann. N. Y. Acad. Sci. 1994, 738:69-75.
3. Bland J.M., Altman D.G. Statistics notes, the odds ratio. BMJ 2000, 320:1468.
4. Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2001, 2:907-916.
5. Brahmachari S., Jana A., Pahan K. Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. J. Immunol. 2009, 183:5917-5927.
6. Brown G.C. Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem. Soc. Trans. 2007, 35:1119-1121.
7. Cárdenas A., Moro M.A., Hurtado O., Leza J.C., Lorenzo P., Castrillo A., Bodelón O.G., Boscá L., Lizasoain I. Implication of glutamate in the expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. J. Neurochem. 2000, 74:2041-2048.
8. Chartrain N.A., Geller D.A., Koty P.P., Sitrin N.F., Nussler A.K., Hoffman E.P., Billiar T.R., Hutchinson N.I., Mudgett J.S. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J. Biol. Chem. 1994, 269:6765-6772.
9. Chomczyński P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993, 15:532-534. 536-537.
10. Chung K.C., Park J.H., Kim C.H., Ahn Y.S. Tumor necrosis factor-alpha and phorbol 12-myristate 13-acetate differentially modulate cytotoxic effect of nitric oxide generated by serum deprivation in neuronal PC12 cells. J. Neurochem. 1999, 72:1482-1488.
11. Corsani L., Bizzoco E., Pedata F., Gianfriddo M., Faussone-Pellegrini M.S., Vannucchi M.G. Inducible nitric oxide synthase appears and is co-expressed with the neuronal isoform in interneurons of the rat hippocampus after transient ischemia induced by middle cerebral artery occlusion. Exp. Neurol. 2008, 211:433-440.
12. Crespi F. The selective serotonin reuptake inhibitor fluoxetine reduces striatal in vivo levels of voltammetric nitric oxide (NO): a feature of its antidepressant activity?. Neurosci. Lett. 2009, 47:95-99.
13. Davis R.L., Buck D.J., Saffarian N., Mohan S., DeSilva U., Fernando S.C., Stevens C.W. Beta-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells. J. Neuroimmune Pharmacol. 2008, 3:150-153.
14. Förstermann U., Closs E.I., Pollock J.S., Nakane M., Schwarz P., Gath I., Kleinert H. Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions. Hypertension 1994, 23:1121-1131.
15. Frodl T, Meisenzahl E.M., Zetzsche T., Born C., Groll C., Jäger M., Leinsinger G., Bottlender R., Hahn K. Hippocampal changes in patients with a first episode of major depression. Am. J. Psychiatry 2002, 159:1112-1118.
16. Fu L., Zhao Y., Lu J., Shi J., Li C., Liu H., Li Y. Functional single nucleotide polymorphism -1026C/A of inducible nitric oxide synthase gene with increased YY1-binding affinity is associated with hypertension in a Chinese Han population. J. Hypertens. 2009, 27:991-1000.
17. Gałecki P., Szemraj J., Bartosz G., Bieńkiewicz M., Gałecka E., Florkowski A., Lewiński A., Karbownik-Lewińska M. Single nucleotide polymorphisms and mRNA expression for melatonin synthesis rate limiting enzyme in recurrent depressive disorder. J. Pineal Res. 2010, 48:311-317.
18. Gałecki P., Florkowski A., Bieńkiewicz M., Szemraj J. Functional polymorphism of cyclooxygenase-2 gene (G-765C) in depressive patients. Neuropsychobiology 2010, 62:116-120.
19. Gałecki P., Szemraj J., Bieńkiewicz M., Florkowski A., Gałecka E. Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Pharmacol. Rep. 2009, 61:436-447.
20. Heales S.J., Bolaños J.P., Stewart V.C., Brookes P.S., Land J.M., Clark J.B. Nitric oxide, mitochondria and neurological disease. Biochim. Biophys. Acta 1999, 1410:215-228.
21. Heneka M.T., Klockgether T., Feinstein D.L. Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J. Neurosci. 2000, 20:6862-6867.
22. Iadecola C., Zhang F., Casey R., Clark H.B., Ross M.E. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke 1996, 27:1373-1380.
23. Kempermann G., Kronenberg G. Depressed new neurons-adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol. Psychiatry 2003, 54:499-503.
24. Kifle Y., Monnier J., Chesrown S.E., Raizada M.K., Nick H.S. Regulation of the manganese superoxide dismutase and inducible nitric oxide synthase gene in rat neuronal and glial cells. J. Neurochem. 1996, 66:2128-2135.
25. Kröncke K.D., Fehsel K., Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol. 1998, 113:147-156.
26. Luo C.X., Zhu X.J., Zhou Q.G., Wang B., Wang W., Cai H.H., Sun Y.J., Hu M., Jiang J., Hua Y., Han X., Zhu D.Y. Reduced neuronal nitric oxide synthase is involved in ischemia-induced hippocampal neurogenesis by up-regulating inducible nitric oxide synthase expression. J. Neurochem. 2007, 103:1872-1882.
27. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., Kubera M., Bob P., Lerer B., Maj M. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab. Brain Dis. 2009, 24:27-53.
28. Maes M., Mihaylova I., Kubera M., Leunis J.C. An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: evidence that nitrosative stress is another factor underpinning the comorbidity between major depression and CFS. Neuro Endocrinol. Lett. 2008, 29:313-319.
29. Maes M., Kubera M., Leunis J.C. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol. Lett. 2008, 29:117-124.
30. Magnusson S., Alm P., Kanje M. Inducible nitric oxide synthase increases in regenerating rat ganglia. Neuroreport 1996, 7:2046-2050.
31. Obregón E., Punzón M.C., González-Nicolás J., Fernandez-Cruz E., Fresno M., Muñoz-Fernández M.A. Induction of adhesion/differentiation of human neuroblastoma cells by tumour necrosis factor-alpha requires the expression of an inducible nitric oxide synthase. Eur. J. Neurosci. 1997, 9:1184-1193.
32. Olivenza R., Moro M.A., Lizasoain I., Lorenzo P., Fernández A.P., Rodrigo J., Boscá L., Leza J.C. Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J. Neurochem. 2000, 74:785-791.
33. Paizanis E., Hamon M., Lanfumey L. Hippocampal neurogenesis, depressive disorders, and antidepressant therapy. Neural Plast. 2007, 737-754.
34. Patel N.J., Chen M.J., Russo-Neustadt A.A. Norepinephrine and nitric oxide promote cell survival signaling in hippocampal neurons. Eur. J. Pharmacol. 2010, 633:1-9.
35. Petrov T., Page A.B., Owen C.R., Rafols J.A. Expression of the inducible nitric oxide synthase in distinct cellular types after traumatic brain injury: an in situ hybridization and immunocytochemical study. Acta Neuropathol. 2000, 100:196-204.
36. Peunova N., Enikolopov G. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 1995, 375:68-73.
37. Poluha W., Schonhoff C.M., Harrington K.S., Lachyankar M.B., Crosbie N.E., Bulseco D.A., Ross A.H. A novel, nerve growth factor-activated pathway involving nitric oxide, p53, and p21WAF1 regulates neuronal differentiation of PC12 cells. J. Biol. Chem. 1997, 272:24002-24007.
38. Saha R.N., Pahan K. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid. Redox Signal. 2006, 8:929-947.
39. Sammut S., Threlfell S., West A.R. Nitric oxide-soluble guanylyl cyclase signaling regulates corticostriatal transmission and short-term synaptic plasticity of striatal projection neurons recorded in vivo. Neuropharmacology 2010, 58:624-631.
40. Stockmeier C.A., Mahajan G.J., Konick L.C., Overholser J.C., Jurjus G.J., Meltzer H.Y., Uylings H.B., Friedman L., Rajkowska G. Cellular changes in the postmortem hippocampus in major depression. Biol. Psychiatry 2004, 56:640-650.
41. Suschek C.V., Krischel V., Bruch-Gerharz D., Berendji D., Krutmann J., Kröncke K.D., Kolb-Bachofen V. Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bcl-2 up-regulation. J. Biol. Chem. 1999, 274:6130-6137.
42. Suzuki E., Yagi G., Nakaki T., Kanba S., Asai M. Elevated plasma nitrate levels in depressive states. J. Affect. Disord. 2001, 63:221-224.
43. Uttenthal L.O., Alonso D., Fernández A.P., Campbell R.O., Moro M.A., Leza J.C., Lizasoain I., Esteban F.J., Barroso J.B., Valderrama R., Pedrosa J.A., Peinado M.A., Serrano J., Richart A., Bentura M.L., Santacana M., Martínez-Murillo R., Rodrigo J. Neuronal and inducible nitric oxide synthase and nitrotyrosine immunoreactivities in the cerebral cortex of the aging rat. Microsc. Res. Technol. 1998, 43:75-88.
44. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell. Biol. 2007, 39:44-84.
45. Wang D., An S.C., Zhang X. Prevention of chronic stress-induced depression-like behavior by inducible nitric oxide inhibitor. Neurosci. Lett. 2008, 433:59-64.
46. Wegener G., Volke V., Harvey B.H., Rosenberg R. Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity. Brain Res. 2003, 959:128-134.
47. World Health Organization, The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Description and Diagnostic Guidelines, Geneva, 1992.
48. Zhang R., Zhang L., Zhang Z., Wang Y., Lu M., Lapointe M., Chopp M. A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats. Ann. Neurol. 2001, 50:602-611.
49. Zhu D.Y., Liu S.H., Sun H.S., Lu Y.M. Expression of inducible nitric oxide synthase after focal cerebral ischemia stimulates neurogenesis in the adult rodent dentate gyrus. J. Neurosci. 2003, 23:223-229.